The decrease in PDK-4 expression after Empagliflozin administration was accompanied by a reduction in fatty acid uptake in the liver, suggesting that the protective effect against obesity would actually be the alteration of PDK-4 induced by Empagliflozin [235]. This evidence concerns the gene PDK4 and obesity disorder.